CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia [Phase 3]
Summary
A Phase 3 clinical trial evaluated single-dose gabapentin for transient insomnia; study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Transient Insomnia | Phase 3 | Status: COMPLETED